​

Coya Therapeutics (COYA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

COYA Stock Forecast

Coya Therapeutics (COYA) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $17.00, with a high of $17.00 and a low of $17.00. This represents a 279.46% increase from the last price of $4.48.

- $4 $8 $12 $16 $20 High: $17 Avg: $17 Low: $17 Last Closed Price: $4.48

COYA Stock Rating

Coya Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

COYA Price Target Upside V Benchmarks

TypeNameUpside
StockCoya Therapeutics279.46%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$17.00
Last Closing Price$4.48$4.48$4.48
Upside/Downside--279.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-7---7
Mar, 26-7---7
Feb, 26-7---7
Jan, 26-7---7
Dec, 25-7---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2025Lake Street$17.00$5.76195.14%279.46%
Sep 16, 2024Raghuram SelvarajuH.C. Wainwright$18.00$6.12194.12%301.79%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 24, 2025H.C. WainwrightBuyBuyhold
Nov 05, 2025Lake StreetBuyBuyhold
Sep 16, 2024H.C. WainwrightBuyinitialise
Jun 12, 2024Rodman & RenshawBuyinitialise
Jun 08, 2023Chardan CapitalBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.79$-0.98$-1.27---
Avg Forecast$-0.87$-1.10$-1.26$-1.30$-0.56$-0.19
High Forecast$-0.31$-1.08$-1.08$-1.29$-0.20$-0.07
Low Forecast$-1.30$-1.11$-1.44$-1.31$-0.83$-0.28
Surprise %-9.20%-10.91%0.79%---

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.00M$3.55M$7.95M---
Avg Forecast$4.05M$3.67M$6.30M$10.00M$15.00M$25.00M
High Forecast$5.57M$3.74M$8.02M$13.75M$20.63M$34.38M
Low Forecast$2.02M$3.59M$4.58M$5.00M$7.50M$12.50M
Surprise %48.20%-3.09%26.12%---

Net Income Forecast

$-25M $-20M $-15M $-10M $-5M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99M$-14.88M$-21.23M---
Avg Forecast$-7.99M$-11.13M$-12.79M$-13.21M$-5.23M$-1.93M
High Forecast$-3.11M$-10.94M$-10.96M$-13.11M$-1.99M$-675.90K
Low Forecast$-13.22M$-11.32M$-14.61M$-13.31M$-8.47M$-2.87M
Surprise %-33.71%66.01%---

COYA Forecast FAQ

Is Coya Therapeutics stock a buy?

Coya Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Coya Therapeutics is a favorable investment for most analysts.

What is Coya Therapeutics's price target?

Coya Therapeutics's price target, set by 5 Wall Street analysts, averages $17 over the next 12 months. The price target range spans from $17 at the low end to $17 at the high end, suggesting a potential 279.46% change from the previous closing price of $4.48.

How does Coya Therapeutics stock forecast compare to its benchmarks?

Coya Therapeutics's stock forecast shows a 279.46% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Coya Therapeutics over the past three months?

  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Coya Therapeutics’s EPS forecast?

Coya Therapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.3, marking a 2.36% increase from the reported $-1.27 in 2025. Estimates for the following years are $-0.56 in 2027, and $-0.19 in 2028.

What is Coya Therapeutics’s revenue forecast?

Coya Therapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $10M, reflecting a 25.85% increase from the reported $7.95M in 2025. The forecast for 2027 is $15M, and $25M for 2028.

What is Coya Therapeutics’s net income forecast?

Coya Therapeutics's net income forecast for the fiscal year ending in December 2026 stands at $-13.213M, representing a -37.75% decrease from the reported $-21.226M in 2025. Projections indicate $-5.229M in 2027, and $-1.931M in 2028.